Global Implantable Neurostimulators Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer. Scope of the Report: In the last several years, United States market of Implantable Neurostimulators developed rapidly, with an average growth rate of 11%. In 2015, United States capacity of Implantable Neurostimulators is nearly 169 k units, the actual production is about 130 k units, and local sales are about 87 k units. Minnesota region is the largest supplier of Implantable Neurostimulators, with a production market share nearly 39%. Massachusetts is the second largest supplier of Implantable Neurostimulators, enjoying production market share nearly 18%. South Atlantic is the largest consumption place, with a consumption market share nearly 23%. Following South Atlantic, Mid-Atlantic Region is the second largest consumption place with the consumption market share of 20%. The worldwide market for Implantable Neurostimulators is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Implantable Neurostimulators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based o ...
Table of Contents 1 Market Overview 1.1 Implantable Neurostimulators Introduction 1.2 Market Analysis by Type 1.2.1 Deep Brain Stimulators 1.2.2 Spinal Cord Stimulators 1.2.3 Vagal Nerve Stimulators 1.2.4 Sacral Nerve Stimulators 1.2.5 Gastric Stimulators 1.2.6 Others 1.3 Market Analysis by Applications 1.3.1 Parkinson's Disease 1.3.2 Epilepsy 1.3.3 Pain 1.3.4 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outl ...
1727

7481

OUR CLIENT